GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Cyclically Adjusted Price-to-FCF

Voyageur Pharmaceuticals (TSXV:VM) Cyclically Adjusted Price-to-FCF : (As of Sep. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Voyageur Pharmaceuticals Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Cyclically Adjusted Price-to-FCF Chart

Voyageur Pharmaceuticals Annual Data
Trend Dec14 Dec15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Voyageur Pharmaceuticals Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.



Voyageur Pharmaceuticals Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Voyageur Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in May. 2024 is calculated as:

For example, Voyageur Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in May. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of May. 2024 (Change)*Current CPI (May. 2024)
=-0.001/127.6007*127.6007
=-0.001

Current CPI (May. 2024) = 127.6007.

Voyageur Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.001 99.473 0.001
201409 -0.007 99.394 -0.009
201412 0.000 98.367 0.000
201503 -0.002 99.789 -0.003
201506 -0.027 100.500 -0.034
201509 -0.001 100.421 -0.001
201512 -0.001 99.947 -0.001
201603 -0.002 101.054 -0.003
201606 -0.006 102.002 -0.008
201609 -0.002 101.765 -0.003
201612 -0.007 101.449 -0.009
201705 -0.009 103.108 -0.011
201708 0.000 103.108 0.000
201711 -0.010 103.740 -0.012
201802 -0.006 104.688 -0.007
201805 -0.001 105.399 -0.001
201808 -0.004 106.031 -0.005
201811 -0.001 105.478 -0.001
201902 -0.002 106.268 -0.002
201905 0.000 107.927 0.000
201908 -0.006 108.085 -0.007
201911 -0.003 107.769 -0.004
202002 -0.004 108.559 -0.005
202005 0.000 107.532 0.000
202008 0.000 108.243 0.000
202011 0.000 108.796 0.000
202102 -0.004 109.745 -0.005
202105 -0.007 111.404 -0.008
202108 -0.003 112.668 -0.003
202111 -0.004 113.932 -0.004
202202 -0.003 115.986 -0.003
202205 -0.001 120.016 -0.001
202208 -0.012 120.569 -0.013
202211 -0.002 121.675 -0.002
202302 -0.004 122.070 -0.004
202305 -0.004 124.045 -0.004
202308 -0.001 125.389 -0.001
202311 0.000 125.468 0.000
202402 -0.001 125.468 -0.001
202405 -0.001 127.601 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Voyageur Pharmaceuticals  (TSXV:VM) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Voyageur Pharmaceuticals Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Voyageur Pharmaceuticals Business Description

Traded in Other Exchanges
Address
333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1
Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.
Executives
Charles Littlejohn 10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines